Calumet Specialty Products Partners, L.P. (NASDAQ:CLMT - Free Report) - Equities researchers at HC Wainwright lowered their Q2 2025 earnings estimates for Calumet Specialty Products Partners in a research note issued to investors on Monday, May 12th. HC Wainwright analyst A. Dayal now anticipates that the oil and gas company will earn ($0.40) per share for the quarter, down from their previous forecast of ($0.34). HC Wainwright currently has a "Buy" rating and a $33.00 target price on the stock. The consensus estimate for Calumet Specialty Products Partners' current full-year earnings is ($3.02) per share. HC Wainwright also issued estimates for Calumet Specialty Products Partners' Q3 2025 earnings at ($0.27) EPS, Q4 2025 earnings at ($0.17) EPS, FY2025 earnings at ($1.88) EPS, FY2026 earnings at ($0.15) EPS, FY2027 earnings at $0.80 EPS and FY2028 earnings at $1.69 EPS.
Other equities analysts have also issued reports about the stock. Wells Fargo & Company cut their price objective on shares of Calumet Specialty Products Partners from $28.00 to $23.00 and set an "overweight" rating on the stock in a report on Wednesday, April 9th. Bank of America initiated coverage on shares of Calumet Specialty Products Partners in a report on Tuesday. They issued a "buy" rating and a $15.00 price objective on the stock. UBS Group upgraded shares of Calumet Specialty Products Partners from a "sell" rating to a "neutral" rating and cut their price objective for the company from $15.00 to $12.00 in a report on Monday, March 17th. TD Cowen lowered shares of Calumet Specialty Products Partners from a "buy" rating to a "hold" rating and cut their price objective for the company from $26.00 to $16.00 in a report on Tuesday, March 4th. Finally, The Goldman Sachs Group cut their price objective on shares of Calumet Specialty Products Partners from $16.00 to $14.00 and set a "buy" rating on the stock in a report on Wednesday, April 30th. One equities research analyst has rated the stock with a sell rating, two have given a hold rating and four have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Hold" and an average price target of $18.83.
View Our Latest Stock Analysis on Calumet Specialty Products Partners
Calumet Specialty Products Partners Price Performance
CLMT opened at $14.00 on Wednesday. Calumet Specialty Products Partners has a one year low of $7.68 and a one year high of $25.29. The company's 50 day simple moving average is $11.23 and its 200-day simple moving average is $16.47. The stock has a market capitalization of $1.21 billion, a P/E ratio of -5.07 and a beta of 0.89.
Calumet Specialty Products Partners (NASDAQ:CLMT - Get Free Report) last released its quarterly earnings results on Friday, May 9th. The oil and gas company reported ($1.03) EPS for the quarter, missing the consensus estimate of ($0.41) by ($0.62). The firm had revenue of $993.90 million for the quarter, compared to analyst estimates of $899.62 million. During the same quarter in the prior year, the business earned ($0.51) earnings per share. Calumet Specialty Products Partners's revenue was down 1.2% compared to the same quarter last year.
Insiders Place Their Bets
In other Calumet Specialty Products Partners news, Director Stephen P. Mawer sold 3,655 shares of the stock in a transaction on Tuesday, April 22nd. The shares were sold at an average price of $9.29, for a total value of $33,954.95. Following the sale, the director now directly owns 283,652 shares in the company, valued at approximately $2,635,127.08. This trade represents a 1.27% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CFO David Lunin bought 2,500 shares of the business's stock in a transaction on Tuesday, March 4th. The stock was purchased at an average price of $13.05 per share, for a total transaction of $32,625.00. Following the completion of the acquisition, the chief financial officer now owns 2,500 shares of the company's stock, valued at approximately $32,625. This trade represents a ∞ increase in their position. The disclosure for this purchase can be found here. Company insiders own 2.91% of the company's stock.
About Calumet Specialty Products Partners
(
Get Free Report)
Calumet, Inc engages in the manufacturing, formulating, and marketing of a diversified slate of specialty branded products and renewable fuels to customers across a broad range of consumer-facing and industrial markets. It operates through the following segments: Specialty Products & Solutions, Performance Brands, Montana/Renewables, and Corporate.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Calumet Specialty Products Partners, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Calumet Specialty Products Partners wasn't on the list.
While Calumet Specialty Products Partners currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.